Tay G K, Witt C S, Christiansen F T, Charron D, Baker D, Herrmann R, Smith L K, Diepeveen D, Mallal S, McCluskey J
Department of Clinical Immunology, Royal Perth Hospital, Australia.
Bone Marrow Transplant. 1995 Mar;15(3):381-5.
Unrelated bone marrow donor-recipient pairs were assessed retrospectively for matching of the HLA-B, -C region (beta-block) and HLA-DR, DQ region (delta block) of the major histocompatibility complex (MHC) using a new DNA-based method referred to as MHC-block typing. The method utilises non-HLA DNA polymorphisms in the MHC as markers of blocks of ancestral haplotypes. Kaplan-Meier analysis of recipients who were matched at both the beta- and delta-blocks revealed a 6 months survival of 54%. Survival was better than for patients who were matched only by conventional criteria, including SSO-typing for class II.